atherosclerosis, coronary disease, ischemic stroke, peripheral arterial disease
DISEASE INTERVENTION COMPARISON RESULTS
Arch Intern Med. 2007 Jun 11;167(11):1122-9 Cohorts
IN atherosclerosis, coronary disease, ischemic stroke, peripheral arterial disease The Use of
chronic kidney disease measures (anemia, microalbuminuria, and GFR of <60 mL/min)
As Etiologic risk factor
Is useful Than
added to classical vascular risk factors
To idependently predict the risk of cardiovascular disease: OR about 1.30 for each one of the 3 measures, OR 1.98 for chronic kidney disease.
BMJ. 2002 Jan 12;324(7329):71-86 Meta-Analysis
IN atherosclerosis, coronary disease, ischemic stroke, peripheral arterial disease The Use of
antiplatelet drugs, aspirin, low-dose (75-150 mg/d), adenosine diphosphate (ADP) receptor inhibitors, clopidogrel
As Treatment, Chronic
Is better Than
placebo
To reduce recurrence of ischemic coronary and cerebral events, with absolute reductions of 3 to 4%, depending on specific conditions